Status:
COMPLETED
EP Intravenous Anesthesia in Hysteroscopy
Lead Sponsor:
RenJi Hospital
Conditions:
Anesthesia
Eligibility:
FEMALE
18-65 years
Phase:
PHASE4
Brief Summary
Hysteroscopy is a gold standard method for evaluating the uterine cavity and diseases, which is gradually becoming a day-surgery in China. Propofol is one of the most commonly used intravenous anesthe...
Detailed Description
Hysteroscopy is a gold standard method for evaluating the uterine cavity and diseases, which is gradually becoming a day-surgery in China. For hysteroscopic surgery using bipolar resectoscopes, hyster...
Eligibility Criteria
Inclusion
- Elective hysteroscopic surgery;
- intravenous anesthesia;
- normal reading and understanding ability
- volunteer to participate
Exclusion
- serious complications such as heart failure, liver failure, pulmonary dysfunction, renal failure, etc.
- predictable difficult airway
- high risk of reflux aspiration
- allergy to propofol or etomidate
- already participated in other clinical trials within three months before admission
- unwilling to cooperate
Key Trial Info
Start Date :
September 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT05259787
Start Date
September 28 2022
End Date
December 30 2023
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127